Insider Title Company Date Price Return Shares Value
Hunt Jonathan Robert Chief Financial Officer Perspective Therapeutics, Inc. (CATX) 2024-11-25 $3.82 0.0% 12,829 $48,974
Hunt Jonathan Robert Chief Financial Officer Perspective Therapeutics, Inc. (CATX) 2024-06-17 $9.81 57.3% 1,800 $17,667
Hunt Jonathan Robert Chief Financial Officer Perspective Therapeutics, Inc. (CATX) 2024-05-31 $14.00 10.3% 2,501 $35,007
Hunt Jonathan Robert Chief Financial Officer Perspective Therapeutics, Inc. (CATX) 2023-12-18 $2.59 496.8% 12,500 $32,338
Return Profit / (loss) Cost
Total 130.2% $174,390 $133,986